Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Dual Therapy”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Post-approval studies (Phase 4)Study completedNCT03897244
What this trial is testing

Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

Who this might be right for
Helicobacter Pylori Infection
National Taiwan University Hospital 603
Large-scale testing (Phase 3)Study completedNCT04311671
What this trial is testing

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Who this might be right for
Onchocerciasis
Medicines Development for Global Health 12,979
Not applicableNot Yet RecruitingNCT07159412
What this trial is testing

Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis

Who this might be right for
Helicobacter Pylori InfectionMetabolic-associated SteatohepatitisHigh-dose Dual Therapy+1 more
Nanjing First Hospital, Nanjing Medical University 286
Testing effectiveness (Phase 2)Study completedNCT00390221
What this trial is testing

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 621
Large-scale testing (Phase 3)UnknownNCT04870190
What this trial is testing

Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases

Who this might be right for
NSCLC
Shanghai Chest Hospital 232
Large-scale testing (Phase 3)Study completedNCT00260923
What this trial is testing

A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure

Who this might be right for
Hypertension
Novartis 641
Large-scale testing (Phase 3)Study completedNCT01028170
What this trial is testing

Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure

Who this might be right for
Congestive Heart FailureRenal Insufficiency
Aspirus Heart and Vascular Institute-Research and Education 50
Early research (Phase 1)Study completedNCT01587365
What this trial is testing

Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins

Who this might be right for
Atherosclerosis
Bristol-Myers Squibb 66
Large-scale testing (Phase 3)Study completedNCT02634580
What this trial is testing

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4

Who this might be right for
Hypercholesterolemia
Amgen 61
Testing effectiveness (Phase 2)Study completedNCT03280030
What this trial is testing

Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 67
Early research (Phase 1)Study completedNCT05481528
What this trial is testing

Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot FlashesHealthy Volunteers
Bayer 51
Large-scale testing (Phase 3)Study completedNCT02075255
What this trial is testing

Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy

Who this might be right for
Asthma
AstraZeneca 220
Large-scale testing (Phase 3)Ended earlyNCT00926575
What this trial is testing

Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)

Who this might be right for
Acute Gastrointestinal Graft vs Host Disease
Soligenix 140
Testing effectiveness (Phase 2)Study completedNCT00298233
What this trial is testing

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Who this might be right for
InfluenzaAvian InfluenzaSevere Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 326
Post-approval studies (Phase 4)Looking for participantsNCT06561698
What this trial is testing

High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine 200
Testing effectiveness (Phase 2)Study completedNCT01669421
What this trial is testing

Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.

Who this might be right for
Alpha 1 Antitrypsin Deficiency
Michael Campos, MD 10
Post-approval studies (Phase 4)Study completedNCT01163435
What this trial is testing

Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication

Who this might be right for
Helicobacter Infection
National Taiwan University Hospital 618
Not applicableStudy completedNCT07121205
What this trial is testing

High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)

Who this might be right for
HELICOBACTER PYLORI INFECTIONS
Liyueyue 1,600
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Testing effectiveness (Phase 2)UnknownNCT01432873
What this trial is testing

Oral Selenium Therapy for the Prevention of Mucositis

Who this might be right for
MucositisHematopoietic Stem Cell Transplantation
Tehran University of Medical Sciences 76
Load More Results